Controlling use of antimicrobials in a community teaching hospital

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Carla PhilmonEdward Goodman

Abstract

To test the hypothesis that antibiotic use could be controlled or improved in a community teaching hospital, with improvement defined as reductions in overall use, overall cost, and antimicrobial resistance. Interventional study with historical comparison. A not-for-profit, 900-bed community general hospital with residents in medicine, surgery, obstetrics-gynecology, and psychiatry. Physicians who requested any of the targeted antibiotics. Three categories of inpatient antibiotic orders were monitored beginning in April 2001: conversion from intravenous to oral administration for selected highly bioavailable antimicrobials, cessation of perioperative prophylaxis within 24 hours for patients undergoing clean and clean-contaminated surgery, and consultation with an infectious diseases physician before continuing administration of selected drugs beyond 48 hours. Data were analyzed after the first 33 months. Patient outcomes were reviewed during the hospital stay and at readmission if it occurred within 30 days after discharge. From April 2001 through December 2003, a total of 1426 requests for antimicrobial therapy met criteria for intervention. Overall physician compliance with the program was 76%, ranging from 57% for perioperat...Continue Reading

References

Dec 12, 1994·Archives of Internal Medicine·M D Arbo, D R Snydman
Jun 1, 1997·Infectious Disease Clinics of North America·J E McGowan, F C Tenover
Sep 25, 1997·JAMA : the Journal of the American Medical Association·B SchwartzJ M Hughes
Aug 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A C WhiteS B Greenberg
Apr 29, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·A J MangramW R Jarvis
Jul 8, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M A Abramson, D J Sexton
Oct 8, 1999·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Aug 5, 2000·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J E PattersonJ H Jorgensen

❮ Previous
Next ❯

Citations

Sep 11, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel P McQuillenLawrence P Martinelli
Aug 19, 2008·The Journal of Perinatal & Neonatal Nursing·Joan Newby
Jan 14, 2011·Current Opinion in Infectious Diseases·Debra A Goff
May 23, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Debra A GoffJessica E West
Sep 28, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Elizabeth S Dodds AshleyElizabeth D Hermsen
Apr 3, 2008·Expert Review of Anti-infective Therapy·Dimple PatelB Joseph Guglielmo
May 15, 2012·American Journal of Infection Control·Anurag N MalaniBonita Singal
Oct 29, 2011·Mayo Clinic Proceedings·Shira Doron, Lisa E Davidson
Jan 12, 2013·Pharmacotherapy·Tina M KhademJack Brown
Sep 18, 2013·Journal of the American College of Surgeons·Shauna M LevyLillian S Kao
Apr 20, 2013·Scandinavian Journal of Infectious Diseases·Elisa García-VázquezJoaquín Ruiz
May 26, 2009·Orvosi hetilap·Edit HajdúErzsébet Nagy
Mar 15, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·August J Valenti
Dec 6, 2014·Hospital Pharmacy·Terri SmithEdward L Goodman
Feb 7, 2018·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·Kevin M KremerLisa M Brennaman
Sep 27, 2018·Antimicrobial Agents and Chemotherapy·Paula ArcenillasEsther Calbo
Oct 30, 2013·Expert Review of Clinical Pharmacology·Rory Sallach-RumaJayashri Sankaranarayanan
Jan 5, 2011·Public Health Nursing·Jeanne Leffers, Emma Mitchell
Aug 5, 2010·Ciência & saúde coletiva·Fernanda d'Athayde Rodrigues, Andréa Dâmaso Bertoldi
Feb 26, 2019·Antimicrobial Resistance and Infection Control·Dilip NathwaniClaudie Charbonneau

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Dominique L Monnet
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
L C McDonaldAntibiotic Use Working Group
© 2021 Meta ULC. All rights reserved